All partnering requests
Seed treatment targeting soybean sudden death syndrome
  • Background
  • What we're looking for
  • What we can offer you
  • Who we are
  • Q&A
Have questions about this request?
Get them answered by the team at UPL.
Background

Sudden Death Syndrome (SDS) is a significant soybean disease caused by Fusarium virguliforme, primarily affecting growers in North America. It is especially prevalent in areas of monoculture soybean production, often exacerbated by the presence of soybean cyst nematode. Current mitigation strategies rely on resistant cultivars and seed-applied synthetic fungicides, primarily from the SDHI (Succinate Dehydrogenase Inhibitor) class. While these fungicides are effective, their long-term sustainability is uncertain due to resistance development, environmental persistence, potential non-target effects, and increasing regulatory scrutiny. 

 

There is a growing need for innovative, environmentally responsible seed treatment approaches to manage SDS in a more sustainable way. Effective alternatives that reduce reliance on conventional chemistries while meeting evolving market and regulatory expectations are critical for long-term disease management in North American soybean production.

What we're looking for

We are looking for environmentally friendly, low-risk seed treatment solutions to prevent or mitigate Fusarium virguliforme, the causal agent of Sudden Death Syndrome (SDS) in soybeans. We are open to partnerships with an existing producer and collaborations where we produce and formulate the solution.

Solutions of interest include:
  • Biological seed treatments using microbial strains
  • Naturally derived antifungal seed-coating compounds
  • Induced resistance activators or plant defense primers
  • Novel chemical classes with low-risk profiles
  • Seed treatments with environmentally friendly modes of action
Our must-have requirements are:
  • Scientific rationale or preliminary evidence supporting compatibility with common fungicides (e.g., fludioxonil and metalaxyl-M)
  • Scientific basis or early data suggesting potential to achieve at least 70% efficacy compared to Fluopyram
  • Target application volume not exceeding 2L per 100 kg of seed
Our nice-to-have's are:
  • Long shelf-life on treated seeds (target: 2 years)
  • Aligns with EU regulations on seed treatments (EC 1107/2009)
What's out of scope:
  • Well-established, in-market solutions or widely commercialized seed treatments
Acceptable technology readiness levels (TRL):
Levels 1-6
What we can offer you
Eligible partnership models:
Co-developmentLicensingSupply/purchaseSponsored research
Benefits:
Sponsored Research
Financial support will be evaluated on a proposal-by-proposal basis. Selected proposals may be eligible for funding starting in 2026, typically ranging from $50,000–$200,000 USD, depending on project scope and stage.
Expertise
Successful applicants will work with experts from UPL’s Seed Applied Technologies division to manage the project.
Tools and Technologies
Our organization offers extensive analytical capabilities that may be made available to support the selected proposal. Relevant technologies include in vitro/in vivo efficacy evaluation, active ingredient quantitation, and mode of action assays. Access to these tools will be considered based on project scope and specific needs.
Data
Access to relevant proprietary data to support solution development and alignment.
Facilities and Services
Successful applicants will have access to UPLs global network of research stations and greenhouse/lab facilities to conduct research year-round.
Who we are

At UPL we are on a mission to Reimagine Sustainability for farmers and food systems – feeding the world while nurturing the planet. Each and every member of our team is making a difference – to our company’s growth, to our industry’s success, and to our sustainable food future. Our employees and teams reflect the diversity of our customers, the regions in which we operate, and the societies we serve.

 Learn more
Reviewers
Q&A with UPL

The Q&A is now closed.

Sort by:
Q.
Regarding "Our must-have requirements are," are these requirements that must be tested during the project or are they requirements that must have been tested before submitting the application?
2
A.
Dear Eduardo, these requirements can be tested during the project. There shouldn´t be evidence that these requirements cannot be met. Best regards Constanze
CH
Constanze Holzfuß, Portfolio Manager, UPL
September 23, 2025
Is this response helpful?
1
0
Q.
I do not understand why you just don't use Trichoderma which has been proven effective. We can certainly develop a specific variant for you that could stop this unless this is not the direction you want to go
2
Sign up to access the full partnering request.
View the details of this request and connect directly with corporate R&D teams at Fortune 500 companies.
Share partnering request
 3 
finalists selected
Refine recommendations
Is this request relevant to you?
Eligible partners
Academic researchersStartupsSuppliers
Seeking partners focused on
Agricultural EngineeringAgricultural ScienceAgronomyAnalytical ChemistryAntimicrobialsBiochemistryBiocidesBiological ComplexityBiomimeticsBiomolecular Processes
39 more

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.